Atlas Trials

Unresectable Breast Carcinoma

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Unresectable Breast Carcinoma

RecordFirmDate
Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC (NCT05233696)University of Colorado, Denver2022-01-04
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer (NCT04673448)University of Washington2021-10-18
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial (NCT04704661)National Cancer Institute (NCI)2021-08-09
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer (NCT03971409)Laura Huppert, MD, BA2019-07-08
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer (NCT03199885)National Cancer Institute (NCI)2019-04-05
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer (NCT01149083)National Cancer Institute (NCI)2010-06-30

Track Unresectable Breast Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.